Welcome to MedDallas!
Welcome to MedDallas.com, Dallas' premier online physician and health professional directory!At MedDallas.com, our goal is to help you makeinformed choices by matching your personal healthcare needs with custom-fit solutions.
More than just a listing of names and addresses, MedDallas.com lets you take a virtual "visit" to our member physicians and organizations. Meet the staff, read physician biographies and certifications, thoroughly understand their practice policies and specialties, fill out pre-registration forms... even get a photo and map of their facilities! We're usingtechnology to improve the level of patient care.
Using MedDallas.com is easy: just select a search category on the Doctor Search page and you're on your way to finding the perfect match for yourpersonal medical needs!
USE OF THIS SITE SIGNIFIES ACCEPTANCE OF OUR TERMS OF SERVICE INCLUDING, WITHOUT LIMITATION, THE USER AGREEMENT.
Please refer to the disclaimer section of this site.
Site Updated December 10, 2001.
 We subscribe to the HONcode principles. Verify here. | Did you know...?
Experts at the American Society of Clinical Oncology (ASCO) meeting often spoke enthusiastically about a growing list of cancer targets and ever-more-ingenious ways to destroy them. The excitement has to do with finding more sophisticated weapons to use to fight the disease. Rather than bludgeon cancer cells with chemicals or radiation--which can harm healthy cells as well--researchers are manipulating biology in an effort to precisely cut off cancer's vast support network. It's a big job. "There are a 160 potential new targets in prostate cancer alone," said Jonathan Simons, a leading gene therapy expert at Johns Hopkins.
But experts are now learning how cancer goes about its dirty work. Some of the problems seem to amount to no more than a big mistake. There are cells that should check cancer growth, but don't. Others have a faulty wiring system that mixes up important messages. Then there is the famous supply system of blood vessels that actually fuel the tumors: Its growth is known as angiogenesis.
By honing in on these key targets, experts say they may have greater success with fewer side effects. So far, the new strategies are mainly wishful thinking. Only two high-tech drugs have been approved for certain cancers, despite many other attempts. But the potential for these types of treatments is huge. Experts at ASCO pointed to a number of experimental strategies that continue to show promise. |
